ATYR
Price
$3.61
Change
-$0.14 (-3.73%)
Updated
Jan 17 closing price
Capitalization
303.03M
67 days until earnings call
VERV
Price
$6.14
Change
+$0.04 (+0.66%)
Updated
Jan 17 closing price
Capitalization
519.84M
39 days until earnings call
Ad is loading...

ATYR vs VERV

Header iconATYR vs VERV Comparison
Open Charts ATYR vs VERVBanner chart's image
aTyr Pharma
Price$3.61
Change-$0.14 (-3.73%)
Volume$670.15K
Capitalization303.03M
Verve Therapeutics
Price$6.14
Change+$0.04 (+0.66%)
Volume$1.65M
Capitalization519.84M
ATYR vs VERV Comparison Chart
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. VERV commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATYR: $3.61 vs. VERV: $6.14)
Brand notoriety: ATYR and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 75% vs. VERV: 104%
Market capitalization -- ATYR: $303.03M vs. VERV: $519.84M
ATYR [@Biotechnology] is valued at $303.03M. VERV’s [@Biotechnology] market capitalization is $519.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 3 bullish TA indicator(s).

  • ATYR’s TA Score: 4 bullish, 6 bearish.
  • VERV’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than ATYR.

Price Growth

ATYR (@Biotechnology) experienced а +2.27% price change this week, while VERV (@Biotechnology) price change was +11.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ATYR is expected to report earnings on May 07, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($520M) has a higher market cap than ATYR($303M). VERV YTD gains are higher at: 8.865 vs. ATYR (-0.276). ATYR has higher annual earnings (EBITDA): -66.11M vs. VERV (-219.97M). VERV has more cash in the bank: 540M vs. ATYR (66M). ATYR has less debt than VERV: ATYR (13.6M) vs VERV (71.3M). VERV has higher revenues than ATYR: VERV (24.4M) vs ATYR (235K).
ATYRVERVATYR / VERV
Capitalization303M520M58%
EBITDA-66.11M-219.97M30%
Gain YTD-0.2768.865-3%
P/E RatioN/AN/A-
Revenue235K24.4M1%
Total Cash66M540M12%
Total Debt13.6M71.3M19%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRVERV
RSI
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with FBIO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then FBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-3.73%
FBIO - ATYR
34%
Loosely correlated
-2.09%
VERV - ATYR
34%
Loosely correlated
+0.66%
MGTX - ATYR
33%
Loosely correlated
+5.56%
SER - ATYR
33%
Loosely correlated
+1.26%
DRUG - ATYR
32%
Poorly correlated
+0.49%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+0.66%
BEAM - VERV
54%
Loosely correlated
+0.17%
CRSP - VERV
53%
Loosely correlated
+0.57%
EDIT - VERV
49%
Loosely correlated
-1.61%
PRME - VERV
49%
Loosely correlated
+0.70%
NTLA - VERV
48%
Loosely correlated
+0.85%
More